Most Recent
Qld tech firm denies using confidential info for battery patent applications
Intellectual Property 2023-10-02 10:00 pm By Cindy Cameronne

Queensland technology company Anteotech has hit back at a lawsuit claiming it misused Ferroglobe’s confidential silicon samples in a patent application after a failed collaboration, saying the global speciality metals producer acquiesced to the use. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis can’t have separate trial on blood pressure drug invalidity claim
Intellectual Property 2023-08-18 10:04 pm By Cindy Cameronne

Novartis has lost its bid to have Pharmacor’s claim that its patent for a blood pressure drug is invalid decided ahead of a main trial where the Swiss pharmaceutical giant will allege the generic drug maker is threatening to infringe its patent. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Ferroglobe accuses ASX company of using confidential IP after failed collaboration
Intellectual Property 2023-07-19 10:52 pm By Gareth Baker

Ferroglobe has claimed a Queensland technology company used its confidential information in new patent applications, as the global specialty metals producer races to protect its IP before the applications are published.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘Substantial industrial theft’: Hytera to face damages for stealing Motorola’s source code
Intellectual Property 2022-12-23 8:59 pm By Cat Fredenburgh

A judge has found Shenzhen-based based radio manufacturer Hytera engaged in “substantial industrial theft” by appropriating Motorola’s source code for its digital mobile radios and should be on the hook for additional damages for “flagrantly” infringing Motorola’s copyright.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis, Pharmacor resolve suit over Gilenya patents
Intellectual Property 2022-11-14 1:42 pm By Cat Fredenburgh

Novartis and and generic drug maker Pharmacor have resolved litigation over the Swiss pharmaceutical giant’s patents for blockbuster MS drug Gilenya.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Biogen, Pharmacor lay down swords in battle over MS drug patent
Intellectual Property 2022-10-31 11:01 pm By Cat Fredenburgh

Swiss pharmaceutical company Biogen and Australian generic drug maker Pharmacor have dropped their claims against one another in a lawsuit over the patent for MS drug Tecfidera. In an October 14 order by Federal Court Justice Helen Rofe, Biogen’s infringement claims and Pharmacor’s cross-claims seeking to invalidate the lucrative patent were discontinued by consent without…

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Defamation, class action barristers among 20 new silks
People In The News 2022-10-06 6:03 pm By Sam Matthews

Twenty barristers have risen to the ranks of senior counsel in New South Wales, including a veteran defamation barrister, two counsel with class action expertise and part of the team that saw ASIC’s claims against two Rio Tinto executives dropped.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Full Court upholds validity of Pfizer’s Dynastat patent
Intellectual Property 2022-09-30 4:58 pm By Cindy Cameronne

A judge has thrown out competing appeals of a decision finding Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bangkok Broadcasting settles ‘7’ trade mark stoush with Seven Network
Intellectual Property 2022-09-05 9:55 pm By Cat Fredenburgh

Bangkok Broadcasting and Seven Networks have settled two lawsuits over the Thai broadcaster’s registration of ‘7’ marks in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Pfizer sues drug companies over Enbrel biosimilar
Intellectual Property 2022-05-10 11:38 pm By Cat Fredenburgh

Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?